Q2 2023 Holdings
Filed 2023-08-11 | 2 holdings | $11.0M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-08-16) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Quidelortho Corp(QDEL) | COM | 219798105 | $51.3M | 619,426 | 19.3% |
| Evolus Inc(EOLS) | COM | 30052C107 | $32.8M | 4,506,197 | 12.3% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $32.4M | 8,793,321 | 12.2% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $27.8M | 682,664 | 10.4% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $24.2M | 1,121,028 | 9.1% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $18.2M | 3,966,916 | 6.8% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $14.4M | 5,500,228 | 5.4% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $13.4M | 2,793,149 | 5.0% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $10.0M | 4,627,224 | 3.8% |
| X4 Pharmaceuticals, Inc.(ASNSUSD)A | COM | 98420X103 | $8.9M | 4,605,263 | 81.0% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $8.7M | 2,946,346 | 3.3% |
| Xoma Corp(XOMA) | COM NEW | 98419J206 | $6.6M | 349,399 | 2.5% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $6.1M | 3,072,476 | 2.3% |
| Tela BIO Inc(TELA) | COM | 872381108 | $4.9M | 482,619 | 1.8% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $4.6M | 448,508 | 1.7% |
| Exagen Inc(XGN) | COM | 30068X103 | $3.0M | 1,049,352 | 1.1% |
| Gamida Cell LTD | SHS | M47364100 | $2.9M | 1,500,000 | 1.1% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $2.8M | 752,088 | 1.1% |
| Delcath Systems, Inc.(DCTH)A | COM NEW | 24661P807 | $2.1M | 378,787 | 19.0% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $1.3M | 91,978 | 0.5% |
| Aytu Biopharma Inc(AYTU) | COM | 054754858 | $755.8K | 472,369 | 0.3% |